1. Home
  2. CYTK vs ZION Comparison

CYTK vs ZION Comparison

Compare CYTK & ZION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Zions Bancorporation N.A.

ZION

Zions Bancorporation N.A.

HOLD

Current Price

$60.22

Market Cap

8.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ZION
Founded
1997
1873
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
ZION
Price
$62.41
$60.22
Analyst Decision
Strong Buy
Hold
Analyst Count
16
19
Target Price
$82.38
$61.05
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
02-26-2026
01-20-2026
Dividend Yield
N/A
2.99%
EPS Growth
N/A
27.47
EPS
N/A
5.59
Revenue
$87,211,000.00
$3,207,000,000.00
Revenue This Year
$346.43
$12.03
Revenue Next Year
$57.69
$4.35
P/E Ratio
N/A
$10.77
Revenue Growth
2609.26
6.54
52 Week Low
$29.31
$39.32
52 Week High
$70.98
$61.57

Technical Indicators

Market Signals
Indicator
CYTK
ZION
Relative Strength Index (RSI) 49.43 64.42
Support Level $62.05 $59.73
Resistance Level $66.59 $61.57
Average True Range (ATR) 2.97 1.14
MACD 0.09 -0.09
Stochastic Oscillator 33.47 70.84

Price Performance

Historical Comparison
CYTK
ZION

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ZION Zions Bancorporation N.A.

Zions Bancorp is a US regional bank with around $90 billion in total assets as of Sept. 30, 2025. Headquartered in Salt Lake City, Utah, Zions' branch network is in the Western and Southwestern United States and includes seven affiliate banks in these markets. The bank has a heavy focus on small and midsize commercial banking.

Share on Social Networks: